Protagonist Therapeutics, Inc financial data

Symbol
PTGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
7707 Gateway Blvd., Suite 140, Newark, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Protagonist Inc (to 9/28/2006)
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.31K % +4.67%
Debt-to-equity 12.3 % +42.2%
Return On Equity 47.7 %
Return On Assets 42.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.4M shares +4.66%
Common Stock, Shares, Outstanding 61M shares +5.76%
Entity Public Float 2B USD +25%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 61.6M shares +8.46%
Weighted Average Number of Shares Outstanding, Diluted 65.1M shares +14.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 138M USD +15%
General and Administrative Expense 43.5M USD +29.8%
Operating Income (Loss) 253M USD +450%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 279M USD +389%
Income Tax Expense (Benefit) 4.22M USD
Net Income (Loss) Attributable to Parent 275M USD +382%
Earnings Per Share, Basic 4.47 USD/shares +289%
Earnings Per Share, Diluted 4.23 USD/shares +272%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 97.2M USD -47.9%
Marketable Securities, Current 322M USD +108%
Other Assets, Current 248K USD +226%
Assets, Current 592M USD +66.4%
Property, Plant and Equipment, Net 3.19M USD +167%
Operating Lease, Right-of-Use Asset 9.42M USD +887%
Assets 745M USD +108%
Accounts Payable, Current 1.62M USD +109%
Accrued Liabilities, Current 23.7M USD +22.4%
Liabilities, Current 47.4M USD +123%
Operating Lease, Liability, Noncurrent 10.4M USD
Liabilities 69.4M USD +226%
Accumulated Other Comprehensive Income (Loss), Net of Tax -82K USD +21.9%
Retained Earnings (Accumulated Deficit) -341M USD +44.7%
Stockholders' Equity Attributable to Parent 675M USD +101%
Liabilities and Equity 745M USD +108%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -27.4M USD +20.1%
Net Cash Provided by (Used in) Financing Activities 7.2M USD -72.8%
Net Cash Provided by (Used in) Investing Activities 6.07M USD -38.2%
Common Stock, Shares Authorized 180M shares +100%
Common Stock, Shares, Issued 61M shares +5.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.2M USD -829%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.5M USD -47.9%
Deferred Tax Assets, Valuation Allowance 115M USD -30.6%
Deferred Tax Assets, Gross 118M USD -29.4%
Operating Lease, Liability 10.9M USD +852%
Payments to Acquire Property, Plant, and Equipment 242K USD +2320%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 275M USD +375%
Lessee, Operating Lease, Liability, to be Paid 12.6M USD +989%
Property, Plant and Equipment, Gross 10.2M USD +37.6%
Operating Lease, Liability, Current 510K USD -55.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.79M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.16M USD -0.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -48.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.77M USD +9211%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.88M USD
Deferred Tax Assets, Operating Loss Carryforwards 8.88M USD -87.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 30.6M USD +9.09%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.98M USD
Operating Lease, Payments 696K USD +3.26%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 236K USD -4.84%
Share-based Payment Arrangement, Expense 37.6M USD +28.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%